Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 4 to 6

Pulpotomy versus partial pulpectomy for deep cavities in primary molars

Official title: Clinical and Radiographic Success Rate of Pulpotomy Versus Pulpectomy for Management of Primary Teeth With Deep Caries: A Randomized Clinical Trial

Run by Cairo University · NCT06293521 · Data updated 2026-11-12

This trial tests whether pulpotomy or partial pulpectomy better treats vital primary molars with deep cavities and irreversible pulpitis in children aged 4 to 6.

Quick facts

PhasePhase 2
Study typeInterventional
Ages4 Years to 6 Years
SexAll
Enrollment40 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedDecember 1, 2026
Main results expectedJanuary 31, 2027
Study endsApril 1, 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT06293521 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy children aged 4–6 with restorable vital primary molars showing deep caries, pulp exposure, and continued bleeding after coronal pulp removal.

Probably not a fit

Children with swelling, pathological mobility, preoperative radiographic pathology (resorption or periradicular/furcation radiolucency), previously accessed teeth, or those unable to attend follow-up visits are unlikely to benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 interventional trial compares clinical and radiographic success rates of pulpotomy (using calcium silicate–based materials) versus partial pulpectomy for vital primary molars with deep caries and signs of irreversible pulpitis. Children aged 4–6 in good general health with restorable, exposed primary molars and prolonged bleeding after coronal pulp removal will be enrolled and treated at Cairo University. Participants will receive one of the two procedures and be followed with clinical exams and dental radiographs at scheduled visits to monitor pain, infection signs, and radiographic healing. Teeth with preoperative radiographic pathology, swelling, or pathological mobility are excluded and outcomes will be compared to determine which approach best preserves tooth function and structure.

Why it matters

Potential benefit: If successful, the less invasive pulpotomy approach could preserve more primary teeth with fewer procedures and complications than pulpectomy.

How similar studies have gone: While calcium silicate–based pulpotomy techniques have shown success in mature permanent teeth and some emerging pediatric reports, high-quality evidence specifically in primary teeth with irreversible pulpitis remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 4 to 6 years , in good general health
2. The parents provided written informed consent.
3. Clinical characteristics, defined as spontaneous pain and the presence of a deep carious lesion with pulp exposure and bleeding that did not halt within five minutes following removal of the coronal pulp tissue.
4. Restorable teeth.

Exclusion Criteria:

1. Physical or mental disability.
2. Unable to attend follow-up visits.
3. Previously accessed teeth.
4. Swelling, tenderness to percussion or palpation, or pathological mobility.
5. Pre-operative radiographic pathology such as resorption (internal or external), per-radicular or furcation radiolucency.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.